Antiviral Drug Resistance in a Chronic Hepatitis B Patient
*Corresponding Author:Received Date: Dec 02, 2024 / Published Date: Dec 31, 2024
Citation: Jeans B (2024) Antiviral Drug Resistance in a Chronic Hepatitis B Patient. J Infect Pathol, 7: 273DOI: 10.4172/jidp.1000273
Copyright: 漏 2024 Jeans B. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Abstract
Antiviral drug resistance is a critical challenge in the management of chronic viral infections, including hepatitis B, HIV, and influenza. This case report highlights the occurrence of antiviral drug resistance in a patient with chronic hepatitis B undergoing long-term therapy with nucleoside analogs. Despite initial virological suppression, the patient exhibited viral breakthrough, prompting the identification of drug-resistant mutations. This report emphasizes the importance of continuous monitoring and the potential need for therapeutic adjustments in the management of antiviralresistant infections
